Erratum to “Epithelial growth factor receptor (EGFR)-inhibition for relief of neuropathic pain–A case series” [Scand. J. Pain 4 (2013) 3–7]

Articles in the same Issue

1. Editorial comment
2. From clear reporting to better research models
3. Topical review
4. Transparency in the reporting of in vivo pre-clinical pain research: The relevance and implications of the ARRIVE (Animal Research: Reporting In Vivo Experiments) guidelines
5. Editorial comment
6. Altered central pain processes behind fibromyalgia? Are they restored by antidepressants as indicated by an innovative fMRI-study?
7. Clinical pain research
8. Using fMRI to evaluate the effects of milnacipran on central pain processing in patients with fibromyalgia
9. Editorial comment
10. The obligation to publishing negative outcome data from neuropathic pain clinical trials
11. Clinical pain research
12. Evaluation of a novel chemokine receptor 2 (CCR2)-antagonist in painful diabetic polyneuropathy
13. Editorial comment
14. Chronic pain and mortality
15. Clinical pain research
16. Mortality rate and causes of death in women with self-reported musculoskeletal pain: Results from a 17-year follow-up study
17. Editorial comment
18. A novel approach of analyzing characteristics of sensory nerve fibers
19. Original experimental
20. Discriminative sensory characteristics of the lateral femoral cutaneous nerve after mepivacaine-induced block
21. Editorial comment
22. Conditioned pain modulation: A useful test paradigm in research and in clinical practice
23. Original experimental
24. Painful heat attenuates electrically induced muscle pain in men and women
25. Editorial comment
26. Amplification of osteoarthritis pain by peripheral and central nervous systems pain mechanisms
27. Original experimental
28. Relating clinical measures of pain with experimentally assessed pain mechanisms in patients with knee osteoarthritis
29. Editorial comment
30. The value of critical values from normative data
31. Clinical pain research
32. Percentile normative values of parameters of electrical pain and reflex thresholds
33. Erratum
34. Erratum to “Epithelial growth factor receptor (EGFR)-inhibition for relief of neuropathic pain–A case series” [Scand. J. Pain 4 (2013) 3–7]